These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 958211)

  • 1. Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.
    Burt DR; Creese I; Snyder SH
    Mol Pharmacol; 1976 Jul; 12(4):631-8. PubMed ID: 958211
    [No Abstract]   [Full Text] [Related]  

  • 2. The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.
    Creese I; Burt DR; Synder SH
    Life Sci; 1975 Dec; 17(11):1715-9. PubMed ID: 1207384
    [No Abstract]   [Full Text] [Related]  

  • 3. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Action of LSD on supersensitive mesolimbic dopamine receptors.
    Kelly PH
    Br J Pharmacol; 1975 Oct; 55(2):291P. PubMed ID: 1201419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serotonin and D-lysergic acid diethylamide receptors in the mammalian brain].
    Vlasova TI; Kirzon MV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (5):5-16. PubMed ID: 6264979
    [No Abstract]   [Full Text] [Related]  

  • 6. Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.
    Bürki HR; Asper H; Ruch W; Züger PE
    Psychopharmacology (Berl); 1978 May; 57(3):227-37. PubMed ID: 97702
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain receptors for dopamine and neuroleptics.
    Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D
    Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446
    [No Abstract]   [Full Text] [Related]  

  • 9. Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover.
    Fuxe K; Agnati LF; Corrodi H; Everitt BJ; Hökfelt T; Löfström A; Ungerstedt U
    Adv Neurol; 1975; 9():223-42. PubMed ID: 1146654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of neurotransmitter receptor binding by ergot derivatives.
    Hruska RE; Silbergeld EK
    J Neurosci Res; 1981; 6(1):1-11. PubMed ID: 6111611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the antagonism of ergot alkaloids and dopamine by phenothiazines.
    Stone TW
    Experientia; 1974 Jul; 30(7):827-9. PubMed ID: 4847689
    [No Abstract]   [Full Text] [Related]  

  • 12. Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain.
    Jalfre M; Ruch-Monachon MA; Haefely W
    Adv Biochem Psychopharmacol; 1974; 10():121-34. PubMed ID: 4276951
    [No Abstract]   [Full Text] [Related]  

  • 13. Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors.
    Prada MD; Saner A; Burkark WP; Bartholini G; Pletscher A
    Brain Res; 1975 Aug; 94(1):67-73. PubMed ID: 1148867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter receptors in the brain: biochemical identification.
    Snyder SH; Bennett JP
    Annu Rev Physiol; 1976; 38():153-75. PubMed ID: 4007
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
    Sibley DR; Creese I
    Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain.
    Rosenfeld MR; Makman MH
    J Pharmacol Exp Ther; 1981 Mar; 216(3):526-31. PubMed ID: 7205633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD labels a novel dopamine receptor in molluscan nervous system.
    Drummond AH; Bucher F; Levitan IB
    Nature; 1978 Mar; 272(5651):368-70. PubMed ID: 24805
    [No Abstract]   [Full Text] [Related]  

  • 18. Biosynthesis of ergot alkaloids in Claviceps paspali. 3. Incorporation of 6-methyl-delta-8,9-ergolene-8-carboxylic acid-14C and lysergic acid-8-3H.
    Agurell S
    Acta Pharm Suec; 1966 Apr; 3(2):65-70. PubMed ID: 5946518
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of methiothepin on cerebral monoamine neurons.
    Lloyd KG; Bartholini G
    Adv Biochem Psychopharmacol; 1974; 10():305-9. PubMed ID: 4846546
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism by derivatives of lysergic acid of the effect of dopamine on Helix neurones.
    Woodruff GN; Walker RJ; Kerkut GA
    Eur J Pharmacol; 1971; 14(1):77-80. PubMed ID: 5555251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.